My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

NRX Pharmaceuticals, Inc. - Common Stock (NQ:NRXP)

2.135 -0.145 (-6.36%)

Streaming Delayed Price Updated: 2:36 PM EST, Nov 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NRX Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

87 Biggest Movers From Yesterday ↗

March 10, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to...

Via Benzinga

NRx Pharmaceuticals Raises $25M Via Equity To Support Its Pipeline Development ↗

January 31, 2022

NRx Pharmaceuticals (NASDAQ: NRXP) has announced the private placement of 7.8 million shares priced at a premium to market under Nasdaq rule, for

Via Benzinga

NRx Pharma's COVID-19 Vaccine Candidate Show Potential Against Omicron Variant ↗

January 27, 2022

NRx Pharmaceuticals (NASDAQ: NRXP) has received scientific evidence from the Israel Institute for Biological Research (IIBR) that the BriLife vaccine can

Via Benzinga

NRx Receives Initial Report of Patient Safety From 'Right To Try' Use Of Zyesami For COVID-19 ↗

January 26, 2022

NRx Pharmaceuticals (NASDAQ: NRXP) has

Via Benzinga

The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute ↗

March 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus AbbVie Settles With Alvotech On Humira Biosimilar Patent Dispute AbbVie, Inc...

Via Benzinga

ROSEN, A TRUSTED AND TOP RANKED LAW FIRM, Encourages NRx Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action NRXP; NRXPW

March 04, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

26 Stocks Moving in Friday's Pre-Market Session ↗

February 18, 2022

Gainers Energy Vault Holdings, Inc. (NYSE: NRGV) rose 34.2% to $14.90 in pre-market trading after jumping around 14% on Thursday. Energy Vault Holdings recently started...

Via Benzinga

52 Biggest Movers From Yesterday ↗

February 15, 2022

Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences...

Via Benzinga

NOTICE: Investors in NRx Pharmaceuticals, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NRXP; NRXPW

February 12, 2022

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

February 08, 2022

Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap...

Via Benzinga

Shareholder Action Alert: The Schall Law Firm Encourages Investors in NRx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

February 04, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Investor Action Reminder: The Schall Law Firm Encourages Investors in NRx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

February 03, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation ↗

February 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Shareholder Action Notice: The Schall Law Firm Encourages Investors in NRx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

February 02, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

NASDAQ:NRXP Investor Notice: Lawsuit Alleges Misleading Statements by NRx Pharmaceuticals, Inc. ↗

February 02, 2022

San Diego, CA -- (SBWIRE) -- 02/02/2022 -- An investor, who purchased shares of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), filed a lawsuit over alleged violations of Federal Securities Laws by NRx...

Via SBWire

Shareholder Action Alert: The Schall Law Firm Encourages Investors in NRx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

February 01, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

NRXP; NRXPW Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NRx Pharmaceuticals, Inc. Investors of Class Action and Lead Plaintiff Deadline: March 21, 2022

February 01, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Mid-Afternoon Market Update: Nasdaq Jumps 375 Points; Imperial Petroleum Shares Drop ↗

January 31, 2022

US stocks recorded gains on the final trading day of January, with the Nasdaq Composite surging more than 350 points on Monday.

Via Benzinga

Investor Action Reminder: The Schall Law Firm Encourages Investors in NRx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

January 31, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Stocks That Hit 52-Week Lows On Monday ↗

January 31, 2022

On Monday morning, 49 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows: The largest company by market cap to hit a new 52-...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 31, 2022

Gainers Calithera Biosciences (NASDAQ:CALA) shares moved upwards by 42.8% to $0.6 during Monday's regular session. As of 12:30 EST, Calithera Biosciences's stock...

Via Benzinga

32 Stocks Moving In Monday's Mid-Day Session ↗

January 31, 2022

Gainers FGI Industries Ltd. (NASDAQ: FGI) shares jumped 42.4% to $5.37 after surging 19% on Friday. The company, last week, priced its IPO at $6 per share. Knightscope, Inc. (...

Via Benzinga

Shareholder Action Notice: The Schall Law Firm Encourages Investors in NRx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

January 28, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NRx Pharmaceuticals, Inc. (NRXP)

January 27, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

Investor Action Reminder: The Schall Law Firm Encourages Investors in NRx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

January 26, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NRx Pharmaceuticals, Inc. (NRXP)

January 26, 2022

From Law Offices of Howard G. Smith

Via Business Wire

The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data ↗

January 26, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Shareholder Action Notice: The Schall Law Firm Encourages Investors in NRx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

January 25, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of NRx Pharmaceuticals, Inc. (NRXP) Investors

January 25, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

Shareholder Action Alert: The Schall Law Firm Encourages Investors in NRx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

January 24, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.